Kotra Research Group is a multidisciplinary research group investigating at the intersection of medicinal chemistry, drug action, preformulations and pre/clinical studies. Kotra laboratory has successfully translated basic research into advanced preclinical and clinical studies. Over the past 20+ years, Kotra lab has maintained high standards to conduct cutting edge research, including those requiring regulatory and/or ethics clearances.
Current research programs in Kotra laboratory include chemical/preclinical/clinical research for clinical solutions for pathologies involving CNS and metabolic systems, antivirals in organ transplant, thrombocytopenia (ITP), chronic rhinosinusitis (CRS), malaria, and disease progression in multiple sclerosis.
We are very proud of our collaborative network who are world-class, committed research groups to help advance the efforts towards meaningful clinical solutions.
Connect with Dr. Kotra via LinkedIn: